Adderall Antitrust Suit Should Stay Buried, 2nd Circ. Hears
Shire LLC pushed back Friday against two drug wholesalers' bid to revive a consolidated class action alleging Shire stifled generic-drug competition for its blockbuster attention deficit hyperactivity disorder treatment Adderall XR,...To view the full article, register now.
Already a subscriber? Click here to view full article